Re: "expert market"??
|
3
|
Zenith Epigenetics
|
Nov 02, 2021 04:59PM
|
Re: Exempt Distribution - 2022-04-14
|
3
|
Resverlogix Corp.
|
Apr 18, 2022 01:25PM
|
Re: Your thoughts please
|
3
|
Resverlogix Corp.
|
Sep 10, 2024 12:46PM
|
Re: Nice problem to have....
|
3
|
Resverlogix Corp.
|
Mar 02, 2020 11:41AM
|
Re: New insights from this study -- Questions for scientists.
|
3
|
Resverlogix Corp.
|
Jun 08, 2022 12:43PM
|
Re: Yahoo poster claims a reverse split coming....
|
3
|
Resverlogix Corp.
|
Nov 10, 2018 11:26AM
|
Re: Numerous Independent Groups Presented Data that Supports Apabetalone's Potential Cardio Benefits at Euro Society of Cardiology Congress 2024
|
3
|
Resverlogix Corp.
|
Sep 03, 2024 10:57AM
|
Re: early report imo
|
3
|
Resverlogix Corp.
|
Jul 03, 2022 01:41PM
|
Re: Pfizer
|
3
|
Zenith Epigenetics
|
Mar 12, 2024 08:12AM
|
Re: Amarin 3 or 5 point MACE
|
3
|
Resverlogix Corp.
|
Feb 13, 2019 10:02AM
|
Re: Lu stepping down
|
3
|
Resverlogix Corp.
|
Feb 21, 2024 07:53PM
|
Re: I followed up with Chris ..
|
3
|
Resverlogix Corp.
|
Nov 09, 2022 01:28PM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
3
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:09AM
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 01:02PM
|
Re: Trading
|
3
|
Resverlogix Corp.
|
Aug 26, 2024 11:09AM
|
Re: What's the deal?
|
3
|
Resverlogix Corp.
|
Nov 28, 2020 05:59PM
|
Re: great,good,bad,ugly or so so??
|
3
|
Resverlogix Corp.
|
May 18, 2022 01:20PM
|
Re: New Covid mutation on the radar -- 'Mu'
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 12:40PM
|
Re: Something "Material" is happening
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 09:37PM
|
Re: Doing up another Seeking Alpha Post....maybe Wednesday
|
3
|
Resverlogix Corp.
|
Mar 24, 2019 05:23PM
|